|
1
|
Coussen LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walczak H: TNF and ubiquitin at the
crossroad of gene activation, cell death, inflammation, and cancer.
Immunol Rev. 244:9–28. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Merga YJ, O'Hara A, Burkitt MD, Duckworth
CA, Probert CS, Campbell BJ and Pritchard DM: Importance of the
alternative NF-κB activation pathway in inflammation-associated
gastrointestinal carcinogenesis. Am J Physiol Gastrointest Liver
Physiol. 310:G1081–G1090. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Correa P: Helicobacter pylori and
gastric carcinogenesis. Am J Surg Pathol. 19 (Suppl 1):S37–S43.
1995.PubMed/NCBI
|
|
5
|
Danesh J: Helicobacter pylori
infection and gastric cancer: Systematic review of the
epidemiological studies. Aliment Pharmacol Ther. 13:851–856. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsujimoto H, Ono S, Ichikura T, Matsumoto
Y, Yamamoto J and Hase K: Roles of inflammatory cytokines in the
progression of gastric cancer: Friends or foes? Gastric Cancer.
13:212–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bockerstett KA and DiPaolo RJ: Regulation
of gastric carcinogenesis by inflammatory cytokines. Cell Mol
Gastroenterol Hepatol. 4:47–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao SP, Mark KG, Leslie K, Pao W, Motoi N,
Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B and Bromberg
JF: Mutations in the EGFR kinase domain mediate STAT3 activation
via IL-6 production in human lung adenocarcinomas. J Clin Invest.
117:3846–3856. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rebouissou S, Amessou M, Couchy G, Poussin
K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P and
Zucman-Rossi J: Frequent in-frame somatic deletions activate gp130
in inflammatory hepatocellular tumours. Nature. 457:200–204. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fukuda A, Wang SC, Morris JP IV, Folias
AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ and
Hebrok M: Stat3 and MMP7 contribute to pancreatic ductal
adenocarcinoma initiation and progression. Cancer Cell. 19:441–455.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johnson DE, O'Keefe RA and Grandis JR:
Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev
Clin Oncol. 15:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Judd LM, Alderman BM, Howlett M, Shulkes
A, Dow C, Moverley J, Grail D, Jenkins BJ, Ernst M and Giraud AS:
Gastric cancer development in mice lacking the SHP2 binding site on
the IL-6 family co-receptor gp130. Gastroenterology. 126:196–207.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Judd LM, Bredin K, Kalantzis A, Jenkins
BJ, Ernst M and Giraud AS: STAT3 activation regulates growth,
inflammation, and vascularization in a mouse model of gastric
tumorigenesis. Gastroenterology. 131:1073–1085. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu P, Wu D, Zhao L, Huang L, Shen G, Huang
J and Chai Y: Prognostic role of STAT3 in solid tumors: A
systematic review and meta-analysis. Oncotarget. 7:19863–19883.
2016.PubMed/NCBI
|
|
16
|
Bowman T, Garcia R, Turkson J and Jove R:
STATs in oncogenesis. Oncogene. 19:2474–2488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buettner R, Mora LB and Jove R: Activated
STAT signaling in human tumors provides novel molecular targets for
therapeutic intervention. Clin Cancer Res. 8:945–954.
2002.PubMed/NCBI
|
|
18
|
Huang S: Regulation of metastases by
signal transducer and activator of transcription 3 signaling
pathway: Clinical implications. Clin Cancer Res. 13:1362–1366.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kamran MZ, Patil P and Gude RP: Role of
STAT3 in cancer metastasis and translational advances. Biomed Res
Int. 2013:4218212013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu CC, Woods AL and Levison DA: The
assessment of cellular proliferation by immunohistochemistry: A
review of currently available methods and their applications.
Histochem J. 24:121–131. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leung WK and Sung JJ: Intestinal
metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther.
16:1209–1216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ushijima T and Sasako M: Focus on gastric
cancer. Cancer Cell. 5:121–125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mitsuyama K, Sata M and Rose-John S:
Interleukin-6 trans-signaling in inflammatory bowel disease.
Cytokine Growth Factor Rev. 17:451–461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao Y, Zhao H, Wang P, Wang J and Zou L:
The roles of SOCS3 and STAT3 in bacterial infection and
inflammatory diseases. Scand J Immunol. 88:e127272018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Shea JJ, Gadina M and Schreiber RD:
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway.
Cell. 109 (Suppl):S121–S131. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kubo M, Hanada T and Yoshimura A:
Suppressors of cytokine signaling and immunity. Nat Immunol.
4:1169–1176. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weber A, Hengge UR, Bardenheuer W,
Tischoff I, Sommerer F, Markwarth A, Dietz A, Wittekind C and
Tannapfel A: SOCS-3 is frequently methylated in head and neck
squamous cell carcinoma and its precursor lesions and causes growth
inhibition. Oncogene. 24:6699–6708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang L, Hu B, Ni J, Wu J, Jiang W, Chen
C, Yang L, Zeng Y, Wan R, Hu G, et al: Transcriptional repression
of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes
pancreatic cancer growth and metastasis. J Exp Clin Cancer Res.
35:272016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang BG, Wang N, Huang J, Yang Y, Sun LL,
Pan ZY and Zhou WP: Tumor SOCS3 methylation status predicts the
treatment response to TACE and prognosis in HCC patients.
Oncotarget. 8:28621–28627. 2017.PubMed/NCBI
|
|
30
|
Galm O, Yoshikawa H, Esteller M, Osieka R
and Herman JG: SOCS-1, a negative regulator of cytokine signaling,
is frequently silenced by methylation in multiple myeloma. Blood.
101:2784–2788. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lindemann C, Hackmann O, Delic S, Schmidt
N, Reifenberger G and Riemenschneider MJ: SOCS3 promoter
methylation is mutually exclusive to EGFR amplification in gliomas
and promotes glioma cell invasion through STAT3 and FAK activation.
Acta Neuropathol. 122:241–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kimura K and Takemoto T: An endoscopic
recognition of the atrophic border and its significance in chronic
gastritis. Endoscopy. 1:87–97. 1969. View Article : Google Scholar
|
|
33
|
Kitahara F, Kobayashi K, Sato T, Kojima Y,
Araki T and Fujino MA: Accuracy of screening for gastric cancer
using serum pepsinogen concentration. Gut. 44:693–697. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Karibe T, Fukui H, Sekikawa A, Shiratori K
and Fujimori T: EXTL3 promoter methylation down-regulates EXTL3 and
heparan sulphate expression in mucinous colorectal cancers. J
Pathol. 216:32–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herman JG, Graff JR, Myohanen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He B, You L, Uematsu K, Zang K, Xu Z, Lee
AY, Costello JF, McCormick F and Jablons DM: SOCS-3 is frequently
silenced by hypermethylation and suppresses cell growth in human
lung cancer. Proc Natl Acad Sci USA. 100:14133–14138. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sekikawa A, Fukui H, Fujii S, Ichikawa K,
Tomita S, Imura J, Chiba T and Fujimori T: REG Ialpha protein
mediates an anti-apoptotic effect of STAT3 signaling in gastric
cancer cells. Carcinogenesis. 29:76–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fukui H, Sekikawa A, Tanaka H, Fujimori Y,
Katake Y, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T and
Fujimori T: DMBT1 is a novel gene induced by IL-22 in ulcerative
colitis. Inflamm Bowel Dis. 17:1177–1188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ogata H, Kobayashi T, Chinen T, Takaki H,
Sanada T, Minoda Y, Koga K, Takaesu G, Maehara Y, Iida M and
Yoshimura A: Deletion of the SOCS3 gene in liver parenchymal cells
promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology.
131:179–193. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tischoff I, Hengge UR, Vieth M, Ell C,
Stolte M, Weber A, Schmidt WE and Tannapfel A: Methylation of
SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's
adenocarcinoma. Gut. 56:1047–1053. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, de Haar C, Chen M, Deuring J,
Gerrits MM, Smits R, Xia B, Kuipers EJ and van der Woude CJ:
Disease-related expression of the IL6/STAT3/SOCS3 signalling
pathway in ulcerative colitis and ulcerative colitis-related
carcinogenesis. Gut. 59:227–235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Issa JP: CpG-island methylation in aging
and cancer. Curr Top Microbiol Immunol. 249:101–118.
2000.PubMed/NCBI
|
|
43
|
Ahuja N, Li Q, Mohan AL, Baylin SB and
Issa JP: Aging and DNA methylation in colorectal mucosa and cancer.
Cancer Res. 58:5489–5494. 1998.PubMed/NCBI
|
|
44
|
Ishimoto H: Epigenetic alterations in
cholangiocarcinoma-sustained IL-6/STAT3 signaling in
cholangio-carcinoma due to SOCS3 epigenetic silencing. Digestion.
79 (Suppl 1):S2–S8. 2009. View Article : Google Scholar
|
|
45
|
Bromberg J: Stat proteins and oncogenesis.
J Clin Invest. 109:1139–1142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rahaman SO, Harbor PC, Chernova O, Barnett
GH, Vogelbaum MA and Haque SJ: Inhibition of constitutively
activate Stat3 suppresses proliferation and induces apoptosis in
glioblastoma multiforme cells. Oncogene. 21:8404–8413. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu WY, Li J, Wu ZS, Zhang CL, Meng XL and
Lobie PE: Prognostic significance of phosphorylated signal
transducer and activator of transcription 3 and suppressor of
cytokine signaling 3 expression in hepatocellular carcinoma. Exp
Ther Med. 2:647–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chiba R, Akiya M, Hashimura M, Oguri Y,
Inukai M, Hara A and Saegusa M: ALK signaling cascade confers
multiple advantages to glioblastoma cells through
neovascularization and cell proliferation. PLoS One.
12:e01835162017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yoshida T, Kato J, Inoue I, Yoshimura N,
Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, et
al: Cancer development based on chronic active gastritis and
resulting gastric atrophy as assessed by serum levels of pepsinogen
and Helicobacter pylori antibody titer. Int J Cancer.
134:1445–1457. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Adachi K, Mishiro T, Tanaka S and
Kinoshita Y: Analysis of negative result in serum anti-H.
pylori IgG antibody test in cases with gastric mucosal atrophy.
J Clin Biochem Nutr. 59:145–148. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Enomoto S, Maekita T, Ohata H, Yanaoka K,
Oka M and Ichinose M: Novel risk markers for gastric cancer
screening: Present status and future prospects. World J
Gastrointest Endosc. 2:381–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Watari J, Chen N, Amenta PS, Fukui H,
Oshima T, Tomita T, Miwa H, Lim KJ and Das KM: Helicobacter
pylori associated chronic gastritis, clinical syndromes,
precancerous lesions, and pathogenesis of gastric cancer
development. World J Gastroenterol. 20:5461–5473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kato M, Nishida T, Yamamoto K, Hayashi S,
Kitamura S, Yabuta T, Yoshio T, Nakamura T, Komori M, Kawai N, et
al: Scheduled endoscopic surveillance controls secondary cancer
after curative endoscopic resection for early gastric cancer: A
multicentre retrospective cohort study by Osaka University ESD
study group. Gut. 62:1425–1432. 2013. View Article : Google Scholar : PubMed/NCBI
|
